| Literature DB >> 17622534 |
Kenan Aksu1, Ayhan Donmez, Yesim Ertan, Gokhan Keser, Vedat Inal, Gonca Oder, Murat Tombuloglu, Yasemin Kabasakal, Eker Doganavsargil.
Abstract
It has been well known that anti-TNF drugs might increase lymphoma risk in rheumatoid arthritis (RA), where the rate of lymphoma has already been increased. However, unlike RA, an increased rate of lymphoma has not been reported in ankylosing spondylitis (AS). Hereby, we present a case with AS developing Hodgkin's lymphoma (HL) following 6 months of etanercept treatment. Pathological analysis revealed mixed cellular type of HL. Although we report a single case, it should be kept in mind that anti-TNF drugs might cause lymphoma development not only in RA, but also in AS.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17622534 DOI： 10.1007/s00296-007-0391-9
Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631